Cancer Targeted Therapy Market Status and Trend Analysis 2017-2026 (COVID-19 Version)

1 RESEARCH SCOPE

1.1 Research Product Definition

1.2 Research Segmentation

1.2.1 Product Type

1.2.2 Main product Type of Major Players

1.3 Demand Overview

1.4 Research Methodology

2 GLOBAL CANCER TARGETED THERAPY INDUSTRY

2.1 Summary about Cancer Targeted Therapy Industry

2.2 Cancer Targeted Therapy Market Trends

2.2.1 Cancer Targeted Therapy Production & Consumption Trends

2.2.2 Cancer Targeted Therapy Demand Structure Trends

2.3 Cancer Targeted Therapy Cost & Price

3 MARKET DYNAMICS

3.1 Manufacturing & Purchasing Behavior in 2020

3.2 Market Development under the Impact of COVID-19

3.2.1 Drivers

3.2.2 Restraints

3.2.3 Opportunity

3.2.4 Risk

4 GLOBAL MARKET SEGMENTATION

4.1 Region Segmentation (2017 to 2021f)

4.1.1 North America (U.S., Canada and Mexico)

4.1.2 Europe (Germany, UK, France, Italy, Rest of Europe)

4.1.3 Asia-Pacific (China, India, Japan, South Korea, Southeast Asia, Australia, Rest of Asia Pacific)

4.1.4 South America (Brazil,, Argentina, Rest of Latin America)

4.1.5 Middle East and Africa (GCC, North Africa, South Africa, Rest of Middle East and Africa)

4.2 Product Type Segmentation (2017 to 2021f)

4.2.1 Tumor Antigens As Targets of Antibodies 

4.2.2 Development of Antibodies for Clinical Purposes 

4.2.3 Complement Dependent Cytotoxicity (CDC) 

4.2.4 Signal Transduction Changes

4.3 Consumption Segmentation (2017 to 2021f)

4.3.1 Hospital 

4.3.2 Clinic 

4.3.3 Others

5 NORTH AMERICA MARKET SEGMENT

5.1 Region Segmentation (2017 to 2021f)

5.1.1 U.S.

5.1.2 Canada

5.1.3 Mexico

5.2 Product Type Segmentation (2017 to 2021f)

5.2.1 Tumor Antigens As Targets of Antibodies 

5.2.2 Development of Antibodies for Clinical Purposes 

5.2.3 Complement Dependent Cytotoxicity (CDC) 

5.2.4 Signal Transduction Changes

5.3 Consumption Segmentation (2017 to 2021f)

5.3.1 Hospital 

5.3.2 Clinic 

5.3.3 Others

5.4 Impact of COVID-19 in North America

6 EUROPE MARKET SEGMENTATION

6.1 Region Segmentation (2017 to 2021f)

6.1.1 Germany

6.1.2 UK

6.1.3 France

6.1.4 Italy

6.1.5 Rest of Europe

6.2 Product Type Segmentation (2017 to 2021f)

6.2.1 Tumor Antigens As Targets of Antibodies 

6.2.2 Development of Antibodies for Clinical Purposes 

6.2.3 Complement Dependent Cytotoxicity (CDC) 

6.2.4 Signal Transduction Changes

6.3 Consumption Segmentation (2017 to 2021f)

6.3.1 Hospital 

6.3.2 Clinic 

6.3.3 Others

6.4 Impact of COVID-19 in Europe

7 ASIA-PACIFIC MARKET SEGMENTATION

7.1 Region Segmentation (2017 to 2021f)

7.1.1 China

7.1.2 India

7.1.3 Japan

7.1.4 South Korea

7.1.5 Southeast Asia

7.1.6 Australia

7.1.7 Rest of Asia Pacific

7.2 Product Type Segmentation (2017 to 2021f)

7.2.1 Tumor Antigens As Targets of Antibodies 

7.2.2 Development of Antibodies for Clinical Purposes 

7.2.3 Complement Dependent Cytotoxicity (CDC) 

7.2.4 Signal Transduction Changes

7.3 Consumption Segmentation (2017 to 2021f)

7.3.1 Hospital 

7.3.2 Clinic 

7.3.3 Others

7.4 Impact of COVID-19 in Europe

8 SOUTH AMERICA MARKET SEGMENTATION

8.1 Region Segmentation (2017 to 2021f)

8.1.1 Brazil

8.1.2 Argentina

8.1.3 Rest of Latin America

8.2 Product Type Segmentation (2017 to 2021f)

8.2.1 Tumor Antigens As Targets of Antibodies 

8.2.2 Development of Antibodies for Clinical Purposes 

8.2.3 Complement Dependent Cytotoxicity (CDC) 

8.2.4 Signal Transduction Changes

8.3 Consumption Segmentation (2017 to 2021f)

8.3.1 Hospital 

8.3.2 Clinic 

8.3.3 Others

8.4 Impact of COVID-19 in Europe

9 MIDDLE EAST AND AFRICA MARKET SEGMENTATION

9.1 Region Segmentation (2017 to 2021f)

9.1.1 GCC

9.1.2 North Africa

9.1.3 South Africa

9.1.4 Rest of Middle East and Africa

9.2 Product Type Segmentation (2017 to 2021f)

9.2.1 Tumor Antigens As Targets of Antibodies 

9.2.2 Development of Antibodies for Clinical Purposes 

9.2.3 Complement Dependent Cytotoxicity (CDC) 

9.2.4 Signal Transduction Changes

9.3 Consumption Segmentation (2017 to 2021f)

9.3.1 Hospital 

9.3.2 Clinic 

9.3.3 Others

9.4 Impact of COVID-19 in Europe

10 COMPETITION OF MAJOR PLAYERS

10.1 Brief Introduction of Major Players

10.1.1 Advaxis 

10.1.2 Bind Therapeutics 

10.1.3 Boehringer Ingelheim 

10.1.4 Bristol Mayer Squibb 

10.1.5 Celldex Therapeutics 

10.1.6 Dendreon Corporation 

10.1.7 Eli Lily 

10.1.8 GalaxoSmithKline 

10.1.9 Galena Biopharma 

10.1.10 Genetech 

10.1.11 ImmunoCellular Therapeutics 

10.1.12 ImmunoGen 

10.1.13 Inovio Pharmaceuticals 

10.1.14 Johnson & Johnson 

10.1.15 NeoStem Oncology 

10.1.16 NewLink Genetics 

10.1.17 Northwest Biotherapeutics 

10.1.18 Merck 

10.1.19 Novartis 

10.1.20 Peregrine Pharmaceuticals 

10.1.21 Pfizer 

10.1.22 Roche 

10.1.23 Sanofi 

10.1.24 Seattle Genetics 

10.1.25 Teva

10.2 Cancer Targeted Therapy Sales Date of Major Players (2017-2020e)

10.2.1 Advaxis 

10.2.2 Bind Therapeutics 

10.2.3 Boehringer Ingelheim 

10.2.4 Bristol Mayer Squibb 

10.2.5 Celldex Therapeutics 

10.2.6 Dendreon Corporation 

10.2.7 Eli Lily 

10.2.8 GalaxoSmithKline 

10.2.9 Galena Biopharma 

10.2.10 Genetech 

10.2.11 ImmunoCellular Therapeutics 

10.2.12 ImmunoGen 

10.2.13 Inovio Pharmaceuticals 

10.2.14 Johnson & Johnson 

10.2.15 NeoStem Oncology 

10.2.16 NewLink Genetics 

10.2.17 Northwest Biotherapeutics 

10.2.18 Merck 

10.2.19 Novartis 

10.2.20 Peregrine Pharmaceuticals 

10.2.21 Pfizer 

10.2.22 Roche 

10.2.23 Sanofi 

10.2.24 Seattle Genetics 

10.2.25 Teva

10.3 Market Distribution of Major Players

10.4 Global Competition Segmentation

11 MARKET FORECAST

11.1 Forecast by Region

11.2 Forecast by Demand

11.3 Environment Forecast

11.3.1 Impact of COVID-19

11.3.2 Geopolitics Overview

11.3.3 Economic Overview of Major Countries

12 REPORT SUMMARY STATEMENT

Table Cancer Targeted Therapy Product Type Overview

Table Cancer Targeted Therapy Product Type Market Share List

Table Cancer Targeted Therapy Product Type of Major Players

Table Brief Introduction of Advaxis 

Table Brief Introduction of Bind Therapeutics 

Table Brief Introduction of Boehringer Ingelheim 

Table Brief Introduction of Bristol Mayer Squibb 

Table Brief Introduction of Celldex Therapeutics 

Table Brief Introduction of Dendreon Corporation 

Table Brief Introduction of Eli Lily 

Table Brief Introduction of GalaxoSmithKline 

Table Brief Introduction of Galena Biopharma 

Table Brief Introduction of Genetech 

Table Brief Introduction of ImmunoCellular Therapeutics 

Table Brief Introduction of ImmunoGen 

Table Brief Introduction of Inovio Pharmaceuticals 

Table Brief Introduction of Johnson & Johnson 

Table Brief Introduction of NeoStem Oncology 

Table Brief Introduction of NewLink Genetics 

Table Brief Introduction of Northwest Biotherapeutics 

Table Brief Introduction of Merck 

Table Brief Introduction of Novartis 

Table Brief Introduction of Peregrine Pharmaceuticals 

Table Brief Introduction of Pfizer 

Table Brief Introduction of Roche 

Table Brief Introduction of Sanofi 

Table Brief Introduction of Seattle Genetics 

Table Brief Introduction of Teva

Table Products & Services of Advaxis 

Table Products & Services of Bind Therapeutics 

Table Products & Services of Boehringer Ingelheim 

Table Products & Services of Bristol Mayer Squibb 

Table Products & Services of Celldex Therapeutics 

Table Products & Services of Dendreon Corporation 

Table Products & Services of Eli Lily 

Table Products & Services of GalaxoSmithKline 

Table Products & Services of Galena Biopharma 

Table Products & Services of Genetech 

Table Products & Services of ImmunoCellular Therapeutics 

Table Products & Services of ImmunoGen 

Table Products & Services of Inovio Pharmaceuticals 

Table Products & Services of Johnson & Johnson 

Table Products & Services of NeoStem Oncology 

Table Products & Services of NewLink Genetics 

Table Products & Services of Northwest Biotherapeutics 

Table Products & Services of Merck 

Table Products & Services of Novartis 

Table Products & Services of Peregrine Pharmaceuticals 

Table Products & Services of Pfizer 

Table Products & Services of Roche 

Table Products & Services of Sanofi 

Table Products & Services of Seattle Genetics 

Table Products & Services of Teva

Table Market Distribution of Major Players

Table Global Major Players Sales Revenue (Million USD) 2017-2020e

Table Global Major Players Sales Revenue (Million USD) Share 2017-2020e

Table Global Cancer Targeted Therapy Market Forecast (Million USD) by Region 2021f-2026f

Table Global Cancer Targeted Therapy Market Forecast (Million USD) Share by Region 2021f-2026f

Table Global Cancer Targeted Therapy Market Forecast (Million USD) by Demand 2021f-2026f

Table Global Cancer Targeted Therapy Market Forecast (Million USD) Share by Demand 2021f-2026f